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1 These authors contribute equally.Interleukin 10 (IL-10) is a potent anti-inﬂammatory cytokine that is crucial for dampening the
inﬂammatory response after pathogen invasion, and was found to be produced by macrophages
after exposure to lipopolysaccharide (LPS). It remains unclear whether microRNA-mediated regula-
tory mechanism is involved in LPS-induced IL-10 production. Here we reported that miR-98 expres-
sion in macrophages signiﬁcantly decreased following LPS stimulation. We also found that miR-98
targets the 3’untranslated region of IL-10 transcript. Overexpression of miR-98 inhibited TLR4-trig-
gered IL-10 production and promoted COX-2 expression. We further demonstrated that miR-98 sig-
niﬁcantly mitigated the induction of endotoxin tolerance, suggesting that miR-98-mediated
posttranscriptional control could potentially be involved in ﬁne tuning the critical level of IL-10 pro-
duction in endotoxin tolerance.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction in vivo. Uncontrolled inﬂammation leads to extensive tissue dam-Toll-like receptors (TLRs) play a critical role in innate immunity
by recognizing a limited but highly conserved set of molecular
structures produced by microorganisms (pathogen-associated
molecular patterns, or PAMPs) [1]. TLR4 recognizes and binds to
LPS to trigger a signaling cascade through the MyD88–dependent
and/or MyD88-independent signaling pathway which eventually
leads to activation of MAPK and NF-jB, resulting in the production
of pro-inﬂammatory cytokines and factors (e.g., TNF-a, IL-1, IL-6
and COX-2). Later in the course of an innate antibacterial immune
response, this burst of pro-inﬂammatory cytokines is followed by
release of anti-inﬂammatory cytokines such as IL-10 and TGF-b
that inhibit the pro-inﬂammatory immune response [2]. Although
these LPS-induced robust and essential inﬂammatory reactions are
indispensable for counteracting the growth and dissemination of
gram-negative bacteria, this process needs to be tightly regulatedchemical Societies. Published by E
ysaccharide; MyD88, myeloid
eukin; TNF-a, tumor necrosis
ng growth factor b; TRIF, TIR-
AF3, TNF receptor-associated
BS, fetal bovine serum; IRF3,
zju.edu.cn (Q. Wang).age, sepsis syndrome, and even endotoxin shock [3]. IL-10 is a ma-
jor anti-inﬂammatory cytokine that is crucial for dampening the
inﬂammatory response after pathogen invasion and acts to protect
the host from excessive inﬂammation [4].
MicroRNAs (miRNAs) are small RNA regulatory molecules
(average 22 nucleotides long) that, when integrated into protein
complexes known as RNA-induced silencing complexes, bind to
partially complementary sequence in the 30-untranslated regions
of target mRNAs and thereby contribute to gene regulation by
inhibiting translation and destabilizing transcripts [5]. miRNAs
regulate the development and function of immune cells [6,7],
and have pivotal roles in the regulation of both innate [8] and
adaptive immune response [9]. miR-146a, miR-155, miR-125b
and miR-21 were shown to inhibit the TLR-triggered inﬂammatory
cytokines [8,10,11]. miR-98 and let-7 were reported to regulate
cytokine-inducible Src homology 2-containing protein (CIS) pro-
tein expression via translational suppression in human cholangio-
cytes [12].
Regulation of IL-10 expression has been extensively studied at
the transcriptional and posttranscriptional levels. Transcription
factors IRF3, Sp1 and Sp3 have been found to regulate IL-10 tran-
scription [13,14]. The AU-rich elements located in the 30-UTR of
these inﬂammatory mediators can be regulated by both miRNAs
and RNA-binding proteins (RBPs). It has been shown that AU-rich
elements in the 30-UTR of mouse IL-10 lead to the degradation oflsevier B.V. All rights reserved.
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mediated regulatory mechanism is involved in IL-10 production
in TLR-triggered macrophages. In the present study, we reported
that down-regulation of miR-98 after LPS exposure partially con-
tributes to LPS-induced IL-10 production, which might be an
important regulatory mechanism for controlling pro-inﬂammatory
immune response and induction of endotoxin tolerance.2. Materials and methods
2.1. Reagents
Lipopolysaccharide (LPS) was purchased from Sigma (St. Louis,
MO). MiR-98 mimics and control mimics were obtained from
GenePharma (Shanghai, China). Anti-COX-2, anti-b-actin and per-
oxidase (HRP)–labeled secondary antibody were purchased from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
2.2. Cell culture and transfection
HEK-293 and RAW 264.7 cell lines were obtained from Ameri-
can Type Culture Collection (Manassas, VA) and cultured in DMEM
containing 10% FBS. 1  104 cells was seeded into 96-well plates
and incubated overnight. JetSI-ENDO transfection reagents (Poly-
plus-transfection) were used for the cotransfection of plasmids
and RNAs, according to the manufacture instructions.
2.3. 30-UTR luciferase reporter assays
The wild type mouse IL-10 30-UTR luciferase reporter vectors
were constructed by amplifying the mouse IL-10 mRNA 30-UTR
and cloning it into Xbal site of PGL3-prooter vector (Promega).
HEK-293 cells were cotransfected with 80 ng luciferase reporter
plasmid, 40 ng thymidine kinase promoter-Renilla luciferase re-
porter plasmid, and the indicated miRNA mimics or controls (ﬁnal
concentration, 20 nM). After 24 h, luciferase activities were mea-
sured using the Dual-Luciferase Reporter Assay System (Promega)
according to the manufacture instructions.
2.4. Detection of cytokine production
IL-10, IL-6 and TNF-a production in the cell supernatants were
measured with ELISA Kits (ebioscience) according to the manufac-
turer’s protocols.
2.5. RNA isolation and real-time quantitative PCR (qPCR)
Total RNA was extracted with TRIzol (Invitrogen). Real-time
quantitative PCR, using SYBR Green detection chemistry, was per-
formed on a 7500 Real-Time PCR System (Applied Biosystems).
2.6. RNA interference
The IL-10-speciﬁc siRNA were 50-ACUGCUAACCGACUCCUUATT-
30 (sense) and 50-UAAGGAGUCGGUUAGCAGUTT-30 (antisense). The
scrambled control RNA sequences were 50-UUCUCCGAACGUGU-
CACGUTT-30 (sense) and 50-ACGUGACACGUUCGGAGAATT-30 (anti-
sense). siRNA duplexes were transfected into RAW 264.7 cells at a
ﬁnal concentration of 10 nM.Fig. 1. LPS inhibits miR-98 expression in RAW 264.7 cells. (A) RAW 264.7 were
treated with indicated dose of LPS for 24 h, the expression of miR-98 was measured
by q-PCR and normalized to the expression of U6. (B) RAW 264.7 cells were
stimulated with LPS (100 ng/ml) for indicated time, and miR-98 expression was
measured. Data are the mean ± S.D. (n = 4) of one representative experiment.
Similar results were obtained in three independent experiments. ⁄P < 0.05;
⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.2.7. Western blot analysis
Total cell lysates were prepared and subjected to SDS/PAGE gel,
transferred onto PVDF membrane, and blotted as we previously de-
scribed [16].2.8. Statistical analysis
All experiments were repeated three times. Data was presented
as the mean ± S.D. Statistical signiﬁcance was determined by Stu-
dent’s t-test, with values of P < 0.05 considered to be statistically
signiﬁcant.
3. Results
3.1. miR-98 is down-regulated in macrophages after LPS stimulation
Previous studies have demonstrated that LPS treatment aug-
ments the expression of several microRNAs such as miR-155 and
miR-146, which have been implicated in LPS response and endo-
toxin shock models [3,17]. To investigate whether miR-98 is also
a regulator of TLR-triggered signaling pathway, we analyzed the
miR-98 expression in RAW 264.7 macrophages after LPS stimula-
tion. As shown in Fig. 1A, miR-98 expression signiﬁcantly de-
creased in LPS stimulated RAW 264.7 macrophage, and the
down-regulation of miR-98 expression by LPS treatment was dose
dependent. We also stimulated these cells with LPS over a time
course. miR-98 levels rapidly decreased and reached the minimum
in 8 h (Fig. 1B). These data demonstrated that miR-98 is constitu-
tively expressed in RAW 264.7 macrophages, and LPS-generated
signals negatively regulated its expression, suggesting that miR-
98 may be involved in the regulation of TLR4 mediated signaling
in macrophages.
3.2. IL-10 is a potential target of miR-98
To identify potential targets for miR-98, we searched for the
miR-98 targets by multiple prediction algorithms (miRBase, PicTar,
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place varying emphases on seed sequence complementarity, het-
eroduplex free energy of binding, location and size of internal loops
and hulges, and accessibility of the target site (as predicted by RNA
binding). This analysis identiﬁed IL-10 as a potential miR-98 target
(Fig. 2A). To certify the possibility that IL-10 was regulated post-
transcriptionally by miR-98, we constructed reporter plasmids by
amplifying the mouse IL-10 mRNA 30-UTR and cloning into XbaI
site of pGL3 vector. By cotransfection of the reporter plasmids
and internal control pRL-TK-Renilla-luciferase plasmids with
miR-98 mimics or the controls (scrambled oligonucleotide) in
HEK-293 cells, we observed that miR-98 mimics markedly de-
creased the luciferase activity in cells transfected with the IL-10
30-UTR vector compared with the controls. No change in luciferase
activity was observed in the PGL3 control vector (Fig. 2B). We fur-
ther examined the luciferase activity of IL-10 mRNA 30-UTR repor-
ter vector in RAW 264.7 macrophages. As shown in Fig. 2C–E, miR-
98 mimics also markedly decreased the luciferase activity in RAW
264.7. LPS treatment signiﬁcantly enhanced the luciferase activity,
and this effect was abrogated by miR-98 mimics.
3.3. LPS-induced up-regulation of IL-10 production was abrogated by
miR-98 mimics
To further examine the role of miR-98 in LPS-induced up-regu-
lation of IL-10 in macrophages, IL-10 mRNA and protein levels
were measured in macrophages after LPS stimulation by qRT-PCR
and ELISA. As shown in Fig. 3A and B, LPS-induced IL-10 protein
expression was signiﬁcantly inhibited in macrophages transfectedFig. 2. IL-10 may be molecular targets of miR-98 posttranscriptional repression. (A) Show
HEK-293 cells (B) or RAW 264.7 cells (C) were cotransfected as described in methods. Aft
activity. (D) RAW 264.7 were transfected with indicated plasmids, 24 h later, cells we
measured. (E) RAW 264.7 were cotransfected with indicated plasmids and miR-98 mimic
ﬁreﬂy luciferase activity was measured. Data are the mean ± S.D. (n = 4) of one represenwith miR-98, but LPS-induced IL-10 transcription was not affected.
We further examined whether LPS-mediated down-regulation of
miR-98 could affect the production of pro-inﬂammatory cytokines.
TNF-a, IL-6 and COX-2 were measured in TLR4-triggered macro-
phages after 12 h. As shown in Fig. 3C–E, it showed no difference
in TNF-a and IL-6 production in RAW 264.7 transfected with
miR-98 mimics and controls. COX-2 protein level increased signif-
icantly in cells transfected with miR-98 mimics compared to con-
trols. These results are consistent with previous observations that
IL-10 inhibits LPS-induced COX-2 expression.
3.4. miR-98 signiﬁcantly mitigates the induction of LPS desensitization
Considering the up-regulation of IL-10 acts as a hallmark of
endotoxin-tolerant macrophages and IL-10 plays a key role in the
regulatory network leading to LPS desensitization, we further
investigated whether LPS-mediated down-regulation of miR-98
was involved in the induction of LPS hyporesponsiveness. RAW
264.7 cells were primed with 10 ng/ml LPS for 18 h, followed by
washing with PBS, cells were incubated in fresh complete culture
medium for 2 h before secondary LPS challenge (1, 10 lg/ml).
Interestingly, RAW 264.7 cells transfected with miR-98 mimics
produced signiﬁcantly higher levels of TNF-a and IL-6 compared
to the cells transfected with controls (scrambled oligonucleotide)
in response to secondary LPS challenge as shown in Fig. 4A.
Furthermore, we found cells transfected with miR-98 mimics pro-
duced signiﬁcantly lower levels of IL-10 in both ﬁrst and secondary
LPS challenge (Fig. 4B). To further investigate whether overexpres-
sion of miR-98 mitigated the induction of LPS desensitization vian is a sequence alignment of miR-98 and its target sites in 30 UTRs of IL-10. 1  104
er 24 h, ﬁreﬂy luciferase activity was measured and normalized by Renilla luciferase
re stimulated with LPS (1 lg/ml) for another 12 h, ﬁreﬂy luciferase activity was
s. After 24 h, cells were stimulated with LPS (1 lg/ml) or PBS for another 12 h, then
tative experiment. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
Fig. 3. miR-98 inhibits the IL-10 production in TLR4-triggered macrophages. RAW 264.7 cells were transfected with miR-98 mimics or controls at a ﬁnal concentration of
20 nM. 24 h later, cells were stimulated with or without LPS (1 lg/ml). Supernatants were collected after 12 or 24 h to measure IL-10 (A), TNF-a (C), and IL-6 (D) by ELISA. (B)
IL-10 mRNA was detected by qRT-PCR in RAW 264.7 stimulated by LPS (1 lg/ml) for indicated time. Data are the mean ± S.D. (n = 4) of one representative experiment.
⁄⁄P < 0.01; ⁄⁄⁄P < 0.001. (E) COX-2 protein level was analyzed by Western blot. Representative of three independent experiments.
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down on the induction of LPS desensitization. siRNA speciﬁc to
mouse IL-10 dramatically inhibited LPS-induced mRNA and protein
expression of IL-10 (Fig. 4C). As shown in Fig. 4D, silencing IL-10 by
siRNA signiﬁcantly mitigates the induction of LPS hyporesponsive-
ness. So, this result indicated that LPS-mediated inhibition of miR-
98 expression is at least partially involved in the induction of LPS
desensitization via up-regulation of IL-10.
4. Discussion
In our study, we detected a signiﬁcant decrease of miR-98
expression in RAW 264.7 cells following LPS stimulation for up
to 24 h. We also demonstrated that miR-98 targets the 30-untrans-
lated region of IL-10 transcripts, therefore, its down-regulation in
response to LPS may be required for proper IL-10 production.
IL-10 are key mediators of the immune response during inﬂam-
mation, stimulated by several endogenous and exogenous factors
such as endotoxin (via Toll-like receptor 4), TNF-a, catecholamines,
and cAMP-elevating drugs [18]. Activation of monocytes by LPS in
the presence of neutralizing anti-IL-10 monoclonal antibodies re-
sulted in the production of higher amounts of cytokines relative
to LPS treatment alone, indicating that endogenously produced
IL-10 inhibited the production of IL-1, IL-6, IL-8, TNF-a [19].
Accordingly, mice become more sensitive to LPS-induced shock
by treatment with anti-IL-10 antibodies [20]. IL-10-deﬁcient mice
developed inﬂammatory bowel disease following colonization of
the gut with particular microorganisms and showed exaggerated
inﬂammatory responses to microbial challenge [21]. IL-10 also playa key role in endotoxin tolerance, which prevents severity of infec-
tions and endotoxin shock [22]. Upregulation of IL-10 through the
TRIF pathway via TRAF3 is the hallmark of endotoxin-tolerant mac-
rophages [23]. Moreover, incubation of PBMCs with IL-10 led to
suppression of LPS-induced TNF-a production, and neutralization
of IL-10 with blocking antibodies during pretreatment of macro-
phages with LPS dramatically mitigated induction of endotoxin tol-
erance [24]. Although LPS tolerance can be induced in IL-10-
deﬁcient mice, Berg et al. reported that while IL-l0 KO mice primed
with 1 lg of LPS survived subsequent challenges of 5–10 lg of LPS,
no survival could be seen when the mice were challenged with
25 lg of LPS. In contrast, wild type mice could resist and survive
10 fold higher doses of LPS. This phenomenon suggested that IL-
10 may play an important but not essential role in induction of
endotoxin tolerance [25].
Since IL-10 plays an important role in immune responses and a
defect in its production has been attributed to certain inﬂamma-
tory diseases, an understanding of the molecular mechanisms that
regulate the expression of this cytokine is crucial [18]. Herein, we
provide a new explanation characterizing the molecular mecha-
nism responsible for IL-10 production after LPS-induced macro-
phage activation. We found that miR-98 expression levels and IL-
10 secretion are inversely correlated. We further conﬁrmed that
IL-10 30-UTR contains the miR-98 binding site. We also demon-
strated that macrophages overexpressing miR-98 before LPS-in-
duced endotoxin tolerance generated more IL-6 and TNF-a after
a second LPS challenge, as compared with the mock control cells.
The resistance to LPS induced endotoxin tolerance might be due
to the down-regulation in IL-10 production which was induced
Fig. 4. Down-regulated miR-98 expression is partially involved in the induction of LPS desensitization. RAW 264.7 cells were transfected with miR-98 mimics at a ﬁnal
concentration of 20 nM. 24 h later, cells primed with 10 ng/ml LPS (10LPS) continuously for 18 h were washed twice with PBS, cells were incubated in fresh complete culture
medium for 2 h before challenged with high doses of LPS (20LPS) for 5 h. Supernatants were collected 5 h after start of LPS challenge to measure TNF-a, IL-6 (A) and IL-10 (B)
by ELISA. (C) RAW 264.7 cells were transfected with IL-10 siRNA or ctrl at a ﬁnal concentration of 10 nM. 24 h later, cells stimulated with 1 lg/ml LPS for 24 h, IL-10 mRNA
(left) and protein (right) were measured by qPCR and ELISA. (D) RAW 264.7 were transfected with IL-10 siRNA or ctrl. 24 h later, cells primed with 10 ng/ml LPS (10LPS)
continuously for 18 h were washed and incubated in fresh complete culture medium for 2 h before challenged with 10 lg/ml LPS (20LPS) for 5 h. Supernatants were collected
to measure TNF-a and IL-6 by ELISA. Data are the mean ± S.D. (n = 4) of one representative experiment from three independent experiments. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
Y. Liu et al. / FEBS Letters 585 (2011) 1963–1968 1967by miR-98 overexpression. So, it suggested that miR-98 mediated
posttranscriptional control could be involved in ﬁne tuning the
critical level of IL-10 expression in endotoxin tolerance.
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